CDMRP: Parkinson’s Research Program (PRP)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The FY26 Parkinson’s Research Program (PRP) will fund innovative, high-impact research aimed at reducing risk, slowing progression, or easing symptoms of Parkinson’s disease. This is a pre-announcement, meaning you have time to prepare—but deadlines have not yet been released. Once funding opportunities are posted on Grants.gov, both pre-application and full application deadlines will be specified. Early preparation is critical to compete.

How much funding would I receive?

Funding depends on the award mechanism:

Early Investigator Research Award

  • Funding Level 1:

    • Up to $300,000 total costs

    • Period of performance: 2 years

  • Funding Level 2:

    • Up to $1,000,000 total costs

    • Period of performance: 2 years

Investigator-Initiated Research Award

  • Up to $2,000,000 total costs

  • Period of performance: 3 years

Total costs include direct and indirect costs.

What could I use the funding for?

Funding supports Parkinson’s disease research aligned to one or more of the following focus areas:

  • Disease heterogeneity and its impact on progression and outcomes

  • Advanced in vitro model systems that reflect in vivo complexity

  • Biomarkers and biological mechanisms tied to unmet medical needs

  • Research addressing:

    • Non-motor symptoms (e.g., cognitive, sleep, psychiatric, pain)

    • Motor symptoms (e.g., tremor, gait, dyskinesia)

  • Development and testing of interventions, including:

    • Biological, pharmacological, and non-pharmacological approaches

    • Surgical and non-surgical devices

    • Non-invasive CNS stimulation

Projects may range from laboratory models to studies involving human participants, depending on the mechanism.

Are there any additional benefits I would receive?

  • Opportunity to work within a Department of Defense-funded research program

  • Access to a program prioritizing clinically relevant, high-impact outcomes

  • Optional Partnering PI structure (Investigator-Initiated Research Award) to support collaboration between two investigators

  • Structured support for early-career researchers, including mentorship (for Funding Level 1)

What is the timeline to apply and when would I receive funding?

  • This is a pre-announcement; application deadlines are not yet specified

  • Funding opportunity announcements will be posted on Grants.gov

  • A pre-application is required via eBRAP before full submission

  • Exact pre-application and full application deadlines will be included in the official announcements

Where does this funding come from?

  • FY26 Defense Appropriations Act

  • Managed by the Congressionally Directed Medical Research Programs (CDMRP)

  • Under the Defense Health Agency Research and Development – Medical Research and Development Command (DHA R&D-MRDC)

Who is eligible to apply?

Early Investigator Research Award

  • Postdoctoral fellows, clinical fellows, or independent investigators within 10 years of degree or residency completion

  • Eligibility must be verified via an institutional statement

Investigator-Initiated Research Award

  • Independent investigators at all academic levels, or equivalent

What companies and projects are likely to win?

Competitive applications will:

  • Address one or more of the specified focus areas

  • Demonstrate high-impact potential and clinical relevance

  • Include:

    • Strong mentorship and career development (early investigators)

    • Preliminary data where required

    • Rigorous, multidisciplinary approaches (Investigator-Initiated Research Award)

  • Target unmet medical needs in Parkinson’s disease, especially across motor and non-motor symptoms

Are there any restrictions I should know about?

Early Investigator Research Award

  • Clinical trials are not allowed

  • Mentorship is required for Funding Level 1

  • Preliminary data:

    • Not required for Level 1

    • Required for Level 2

Investigator-Initiated Research Award

  • Preliminary data are required

  • Clinical trials are allowed

General

  • Pre-application submission via eBRAP is required

  • Applications must follow final instructions in the official funding announcements

How long will it take me to prepare an application?

  • Not specified in the pre-announcement

  • However, the requirement for a pre-application and full application, along with preliminary data (for most mechanisms), indicates a moderate to high preparation effort

How can BW&CO help?

BW&CO can support you by:

  • Interpreting the full funding announcement once released

  • Positioning your project against PRP focus areas and review criteria

  • Developing a compelling technical narrative and commercialization angle

  • Managing pre-application and full submission workflows

  • Supporting teaming strategies, including Partnering PI structures

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.

Additional Resources

Review the solicitation here.

Previous
Previous

DevX Autonomy: Open Call Solicitation for Innovative AUS Solutions

Next
Next

CDMRP: Duchenne Muscular Dystrophy Research Program (DMDRP)